Valentina Pagliara

Via Salvador Allende 43
Baronissi, 84031, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Journal: Journal of medicinal chemistry

Published: February 23, 2026

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Journal: Cancer communications (London, England)

Published: December 16, 2025

rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

Journal: Journal for immunotherapy of cancer

Published: November 05, 2025

BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.

BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.

Journal: Current oncology reports

Published: October 19, 2025

Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature.

Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature.

Journal: MedScience

Published: September 27, 2025

CLIC2 regulates immunosuppression and macrophage differentiation in genomically stable gastric cancer.

CLIC2 regulates immunosuppression and macrophage differentiation in genomically stable gastric cancer.

Journal: Biology direct

Published: February 19, 2025

Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.

Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.

Journal: Translational oncology

Published: February 14, 2025

Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors.

Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Scientific reports

Published: January 25, 2025

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.

Journal: Frontiers in immunology

Published: April 18, 2024

Inhibition of Interleukin-6 Dependent Metalloproteinases-9/2 Expression in Cancer Cells by Diet Polyphenols.

Inhibition of Interleukin-6 Dependent Metalloproteinases-9/2 Expression in Cancer Cells by Diet Polyphenols.

Journal: Anti-inflammatory & anti-allergy agents in medicinal chemistry

Published: March 28, 2023

Myogenesis in C2C12 Cells Requires Phosphorylation of ATF6α by p38 MAPK.

Myogenesis in C2C12 Cells Requires Phosphorylation of ATF6α by p38 MAPK.

Journal: Biomedicines

Published: March 12, 2023

Cocoa Extract Provides Protection against 6-OHDA Toxicity in SH-SY5Y Dopaminergic Neurons by Targeting PERK.

Cocoa Extract Provides Protection against 6-OHDA Toxicity in SH-SY5Y Dopaminergic Neurons by Targeting PERK.

Journal: Biomedicines

Published: July 27, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026